Mirae Asset Global Investments »

Zenas Biopharma shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $95k 2.6k 36.31

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Palantir Technologies Cl A (PLTR)

View all positions for Mirae Asset Global Investments

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma